Evidence map›Paper›PMID 40900934›Full record

ArticleBulletin of the World Health Organization2025

Cigarette consumption from a life-course perspective in low- and middle-income countries.

Mark Goodchild, Jeremias Paul, Ruediger Krech

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mark GoodchildHealth Promotion Department, World Health Organization, 20 Avenue Appia, 1211Geneva, Switzerland.
Jeremias PaulHealth Promotion Department, World Health Organization, 20 Avenue Appia, 1211Geneva, Switzerland.
Ruediger KrechHealth Promotion Department, World Health Organization, 20 Avenue Appia, 1211Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Objective: To calculate the total life-course expenditure of smokers on cigarettes alone, before or without accounting for any economic losses as a result of smoking-attributable death and disease. Method: We used data from Global Adult Tobacco Surveys to calculate annual cigarette consumption and expenditure in 15 low- and middle-income countries. We extracted data on average earnings from the ILOSTAT database of the International Labour Organization. We calculated life-course cigarette expenditures using cohort life expectancies and inflation, and converted these expenditures into net present value terms using a 3% social discount rate. Findings: The average age of adult cigarette smokers in our sample was 40 years, and their average expenditure on cigarettes was equivalent to 7.2% of annual average earnings. Given an average life expectancy of 55 years at the age of 15 years, we estimated an average life-course consumption of 217 752 cigarettes and a full life-course expenditure of 8481 United States dollars (US$) in net present value terms, more than twice the current average annual earnings of workers. However, by quitting, current adult smokers can avoid an average of US$ 6612 in expenditure on cigarettes over their remaining life-course. Conclusion: The affordability of cigarettes is an important determinant of cigarette use and tax policies can have a large effect on consumers, especially young adults. These costs will only increase over time as governments continue to raise taxes to address the market failures inherent within the tobacco market.

Indexed as

Developing CountriesSmokingTobacco ProductsAdolescentAdultFemaleGlobal HealthHumansLife ExpectancyMaleMiddle AgedTaxesYoung Adult

Identifiers

PMID40900934
PMCPMC12399996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.